Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-19
2008-12-16
Saeed, Kamal (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S364100, C548S364400, C514S406000
Reexamination Certificate
active
07465808
ABSTRACT:
There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.
REFERENCES:
patent: 4826868 (1989-05-01), Wachter et al.
patent: 5051518 (1991-09-01), Murray et al.
patent: 5164381 (1992-11-01), Wachter et al.
patent: 6750230 (2004-06-01), Corbau et al.
patent: 6750239 (2004-06-01), Hale et al.
patent: 6784185 (2004-08-01), Allerton et al.
patent: 6815428 (2004-11-01), Ohsumi et al.
patent: 6838458 (2005-01-01), Sakya
patent: 6846838 (2005-01-01), Slusarchyk et al.
patent: 6849653 (2005-02-01), Clare et al.
patent: 6852717 (2005-02-01), Cirillo et al.
patent: 6875789 (2005-04-01), Tang et al.
patent: 7037931 (2006-05-01), Barrett et al.
patent: 0 467 614 (1992-01-01), None
patent: 0293220 (1994-08-01), None
patent: WO 95/04720 (1995-02-01), None
patent: WO 97/11704 (1997-04-01), None
patent: WO 97/46534 (1997-11-01), None
patent: WO 97/46534 (1997-12-01), None
patent: WO 01/66539 (2001-09-01), None
patent: WO 01/85723 (2001-11-01), None
patent: WO 01/85724 (2001-11-01), None
patent: WO 01/90078 (2001-11-01), None
patent: WO 03/24958 (2003-03-01), None
patent: WO 03/024958 (2003-03-01), None
patent: WO 04/007463 (2004-01-01), None
patent: WO 2004/007463 (2004-01-01), None
Gigoux, V. et al. Arginine 336 and Asparagine 333 of the Human Cholecystokinin-A Receptor Binding Site Interact with the Penultimate Aspartic Acid and the C-terminal Amide of Cholecystokinin. J. Biol. Chem. 1999, 274(29):20457-20464.
Harper, E.A. et al. Analysis of Variation in L-365,260 Competition Curves in Radioligand Binding Assays. Br. J. Pharmacol. 1996, 118:1717-1726.
Hull, R.A. et al. 2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)-A Selective Cholecystokinin CCKA-Receptor Antagonist. Br. J. Pharmacol. 1993, 108:734-740.
Klapars, A. et al. A General and Efficient Copper Catalyst for the Amidation of Aryl Halides and the N-Arylation of Nitrogen Heterocycles. J. Am. Chem. Soc. 2001, 123(31):7727-7729.
Klausner, Y.S. and Bodanszky, M. The Azide Method in Peptide Synthesis: Its Scope and Limitations. Synthesis 1974, 8:549-559.
Moradi, W.A. and Buchwald, S.L. Palladium-Catalyzed alpha-Arylation of Esters. J. Am. Chem. Soc. 2001, 123(33):7996-8002.
Morton, M.F. et al. Pharmacological Comparison of the Alternatively Spliced Short and Long CCK2 Receptors. Br. J. Pharmacol. 2003, 140(1):218-224.
Murray, W.V. et al. Synthesis of 3-(1,5-Diphenyl-3-pyrazolyl)aryl Propanates. J. Heterocycl. Chem. 1990, 27:1933-1940
Penning, T.D. et al. Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfo- namide (SC-58635, Celecoxib). J. Med. Chem. 1997, 40(9):1347-1365.
Saito, T. et al. Total Synthesis of the Furaquinocins. J. Am. Chem. Soc. 1998, 120(45):11633-11644.
Shen, D.-M. et al. Versatile and Efficient Solid-Phase Syntheses of Pyrazoles and Isoxazoles. Organic Letters 2000, 2(18):2789-2792.
Tullio, P. et al. Therapeutic and Chemical Developments of Cholecystokinin Receptor Ligands. Exp. Opin. Invest. Drugs 2000, 9(1):129-146.
Wang, Z. et al. A New Synthesis for Methyl 2-Benzyloxyphenylacetate. Synth. Commun. 1999, 29(13):2361-2364.
Wolfe, J.P. et al. Simple Efficient Catalyst System for the Palladium-Catalyzed Amination of Aryl Chlorides, Bromides, and Triflates. J. Org. Chem. 2000, 65(4):1158-1174.
Kirby et al., Journal of Organic Chemistry, 1963, vol. 28(9), pp. 2266-2271.
Alberola et al Synth Commun 1986 vol. 16(6) pp. 673-680.
Alberola et al Heterocycles 2001 vol. 55(2) pp. 331-351.
Bohrisch et al Synthesis 1991 vol. 12 pp. 1153-1156.
Buchwald J Org Chem 2000 vol. 65 pp. 1158-1174.
Cabarrocas et al Tetrahedron Assymetry 2000 pp. 11(12) pp. 2483-2493.
Cheng and Prusoff Biochem Pharmacol 1973 vol. 22 pp. 3099-3108.
Chowdhury et al Tetrahedron 1999 vol. 55(22) pp. 7011-7016.
De La Cal et al Synth Commun 1989 vol. 19(5) pp. 1039-1045.
De Tullio et al Exp Opinion Invest Drugs 2000 vol. 9(1) pp. 129-146.
Evans et al., J Am Chem Soc 1990 vol. 112(10) pp. 4011-4030.
Gonzales et al Synth Commun 1995 vol. 275(7) pp. 1005-1014.
Huang et al Org Lett 2000 vol. 2(18) pp. 2833-2836.
Jeong et al Tetrahedron Lett 2002 vol. 43(4) pp. 7171-7174.
Karpov et al Synthesis 2003 vol. 18 pp. 2815-2826.
Larsen et al J Am Chem Soc 1989 vol. 111(19) pp. 7650-7651.
Michael et al Pure Appl Chem 1999 vol. 71(6) pp. 979-988.
Miller et al J. Heterocyl Chem 1993 vol. 30 pp. 755-763.
Molteni et al Synthesis 2002 vol. 12 pp. 1669-1674.
Moradi et al J Am Chem Soc 2001 vol. 123 pp. 7996-8002.
Murray et al J Heterocycl Chem 1989 vol. 26 pp. 1389-1392.
Nahm et al Tetrahedron Lett 1981 vol. 22(39) pp. 3815-3818.
Ochiai et al J Chem Soc Chem Commun 1990 vol. 2 pp. 118-119.
Saito et al. J. Am. Chem. Soc. 1998 vol. 120 p. 11633.
Seko et al Tetrahedron Lett 1996 vol. 39(44) pp. 8117-8120.
Sibi et al Org Prep Proced Int 1993 vol. 25(1) pp. 15-40.
Smirnova et al Russ Chem Rev (Engl Transl) 2000 vol. 69(12) pp. 1021-1036.
Wang et al Tetrahedron Lett 2000 vol. 41(24) pp. 4713-4716.
Barrett Terrance D.
Breitenbucher J. Guy
Gomez Laurent
Hack Michael D.
Huang Liming
Janssen Pharmaceutica N.V.
Nolan Jason M
Saeed Kamal
LandOfFree
CCK-1 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CCK-1 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCK-1 receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4026285